ANTIBACTERIAL ACTIVITY OF CEFTIZOXIME (CZX), A NEW CEPHALOSPORIN AGAINST BACTERIA WHOSE RESISTANCE IS MEDIATED BY PLASMID OR CHROMOSOMAL GENES AND STABILITY OF THE ANTIBIOTIC TO β-LACTAMASE
スポンサーリンク
概要
- 論文の詳細を見る
Antibacterial activity of ceftizoxime against ampicillin resistant clinical isolates of <I>Escherichia coil</I> was compared with those of other newly developed cephalosporins. CZX was the most active against strains possessing R-plasmids specifying ampicillin resistance and those whose resistance was chromosomally determined.<BR>The susceptibility of ampicillin-sensitive <I>E. coli</I> to CZX was not decreased by transduction of ampicillinresistance specifying plasmids. However, most of the transconjugants acquired a high level of resistance to cefoperazone and cefamandole and a moderate level to cefotiam.<BR>CZX was highly stable to both penicillinase and cephalosporinase type β-lactamases including R-plasmid mediated β-lactamase. Its level of resistance to β-lactamases was comparable to cefoxitin, cefmetazole and cefotaxime, slightly superior to cefuroxime and much superior to cefotiam, cefamandole and cefoperazone.
- 公益社団法人 日本化学療法学会の論文
公益社団法人 日本化学療法学会 | 論文
- DISPOSITION OF 7432-8 IN RATS (I)
- CLINICAL STUDIES ON T-1220 IN SURGICAL CASES
- CLINICAL STUDIES OF PIVALOYLOXYMETHYL D-α-AMINOBENZYL-PENICILLINATE HYDROCHLORIDE IN SURGICAL INFECTIONS
- STUDIES ON AC-1370
- Primary treatment with a combination of cyclophosphamide, vincristine, and dacarbazine for recurrent malignant pheochromocytoma: A case report.